Related Experiment Video
Updated: May 10, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Assessment of tuberculosis burden in China using a dynamic disease simulation model
Drug-susceptible tuberculosis (DS-TB) is projected to decrease in China by 2050, while multidrug-resistant tuberculosis (MDR-TB) is expected to rise significantly. Improved diagnosis and treatment of MDR-TB are crucial to combat this growing threat.
Area of Science:
- Epidemiology
- Public Health
- Infectious Disease Modeling
Background:
- Tuberculosis (TB) remains a leading global cause of death, with multidrug-resistant TB (MDR-TB) emerging as a critical challenge from inadequately treated drug-susceptible TB (DS-TB).
- Understanding the epidemiological drivers of both DS-TB and MDR-TB in China is essential for effective control strategies.
Purpose of the Study:
- To analyze the primary factors influencing the incidence and prevalence of DS-TB and MDR-TB in China.
- To project future trends in TB burden using a sophisticated modeling approach.
Main Methods:
- Utilized the Tuberculosis Disease Transmission Model (TBDTM), incorporating historical and current epidemiological data, transmission dynamics, and treatment effectiveness.
- Accounted for annual changes in these parameters to forecast future DS-TB and MDR-TB burden.
Main Results:
- By 2050, China is projected to see a 32% decrease in DS-TB incidence, a 50% reduction in prevalence, and a 41% drop in mortality.
- Conversely, MDR-TB incidence, prevalence, and mortality are expected to increase by 60%, 48%, and 35%, respectively.
- DS-TB reduction is linked to high treatment success, decreasing latent infection prevalence, while MDR-TB rise is attributed to treatment failures and subsequent transmission.
Conclusions:
- The study predicts a decline in DS-TB but a significant increase in MDR-TB in China over the next four decades.
- Urgent improvements in MDR-TB diagnosis and treatment are necessary to mitigate its escalating impact.
- The TBDTM offers a valuable tool for public health, aiding in the evaluation of intervention impacts and cost-effectiveness.
More Related Videos
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Modeling with Differential Equations
Steps in Outbreak Investigation